Results of a recently published long-term follow-up of the ASAP trial, which was conducted at universities and clinics across ...

Management of newly diagnosed acute myeloid leukemia (AML) in patients deemed unfit for intensive chemotherapy is undergoing ...

The selection of patients for allo-HSCT and the best approach to bridging patients to transplantation is continuously ...

Orca-T is an allogeneic T-cell immunotherapy that consists of purified regulatory T-cells, hematopoietic stem cells and conventional T-cells derived from peripheral blood.

Danika Hilmer, a stay-at-home mother-of-three from Iowa, has revealed how giving birth to her son at age 32 in 2022 turned ...

Surjeet turned emotional as he recalled how his son got a new lease of life after undergoing one year of treatment at the ...

The Oneida Common Council recognized September as Childhood Cancer Awareness Month during its recent meeting. The council ...

The authors found comparable results among patients in all 3 donor categories. For instance, the 2-year overall survival (OS) ...

This anonymous hero gave us hope after my spouse’s leukemia diagnosis. Reaching out to thank him led to an unexpected online ...

Cancer remains one of humanity’s most formidable challenges, claiming the lives of millions every year despite decades of medical progress. While some cancers respond well to treatment when diagnosed ...

Among patients with advanced gastrointestinal stromal tumors (GISTs), treatment with Gleevec (imatinib) is associated with long-term effectiveness — with complete surgical removal, or resection, of ...

In patients with myeloproliferative neoplasms (MPNs), cardiovascular risk factors (CVRFs) appeared predictive of poorer overall survival (OS) and thrombosis in a study published in the journal Blood ...